Literature DB >> 26240675

FOCUS ON PSORIASIS: A REPORT FROM THE 73RD ANNUAL MEETING OF THE AMERICAN ACADEMY OF DERMATOLOGYPsoriasis-related topics included targeted therapies, safety of biologies, comorbidities.

Jessica M Donigan1.   

Abstract

Entities:  

Year:  2015        PMID： 26240675      PMCID： PMC4521138     

Source DB:  PubMed          Journal:  J Clin Aesthet Dermatol        ISSN： 1941-2789


× No keyword cloud information.
  21 in total

1.  Increased risk of psoriasis following obstructive sleep apnea: a longitudinal population-based study.

Authors:  Ya-Wen Yang; Jiunn-Horng Kang; Herng-Ching Lin
Journal:  Sleep Med       Date:  2012-01-30       Impact factor: 3.492

Review 2.  The long-term safety of adalimumab treatment in moderate to severe psoriasis: a comprehensive analysis of all adalimumab exposure in all clinical trials.

Authors:  Craig Leonardi; Kim Papp; Bruce Strober; Kristian Reich; Akihiko Asahina; Yihua Gu; Joseph Beason; Stephen Rozzo; Stephen Tyring
Journal:  Am J Clin Dermatol       Date:  2011-10-01       Impact factor: 7.403

3.  Effect of 1-year anti-TNF-α therapy on aortic stiffness, carotid atherosclerosis, and calprotectin in inflammatory arthropathies: a controlled study.

Authors:  Kristin Angel; Sella A Provan; Magne K Fagerhol; Petter Mowinckel; Tore K Kvien; Dan Atar
Journal:  Am J Hypertens       Date:  2012-03-01       Impact factor: 2.689

4.  Might psoriasis be a risk factor for obstructive sleep apnea syndrome?

Authors:  Semsettin Karaca; Fatma Fidan; Faruk Erkan; Serkan Nural; Tulay Pinarcı; Ersin Gunay; Mehmet Unlu
Journal:  Sleep Breath       Date:  2012-03-15       Impact factor: 2.816

5.  Association between psoriasis and chronic obstructive pulmonary disease: a population-based study in Taiwan.

Authors:  Y-Y Chiang; H-W Lin
Journal:  J Eur Acad Dermatol Venereol       Date:  2011-03-09       Impact factor: 6.166

6.  Attributable risk estimate of severe psoriasis on major cardiovascular events.

Authors:  Nehal N Mehta; YiDing Yu; Rebecca Pinnelas; Parasuram Krishnamoorthy; Daniel B Shin; Andrea B Troxel; Joel M Gelfand
Journal:  Am J Med       Date:  2011-08       Impact factor: 4.965

7.  The effect of systemic psoriasis therapies on the incidence of myocardial infarction: a cohort study.

Authors:  K Abuabara; H Lee; A B Kimball
Journal:  Br J Dermatol       Date:  2011-11       Impact factor: 9.302

8.  Association between tumor necrosis factor inhibitor therapy and myocardial infarction risk in patients with psoriasis.

Authors:  Jashin J Wu; Kwun-Yee T Poon; Jennifer C Channual; Albert Yuh-Jer Shen
Journal:  Arch Dermatol       Date:  2012-11

9.  Secukinumab in plaque psoriasis--results of two phase 3 trials.

Authors:  Richard G Langley; Boni E Elewski; Mark Lebwohl; Kristian Reich; Christopher E M Griffiths; Kim Papp; Lluís Puig; Hidemi Nakagawa; Lynda Spelman; Bárður Sigurgeirsson; Enrique Rivas; Tsen-Fang Tsai; Norman Wasel; Stephen Tyring; Thomas Salko; Isabelle Hampele; Marianne Notter; Alexander Karpov; Silvia Helou; Charis Papavassilis
Journal:  N Engl J Med       Date:  2014-07-09       Impact factor: 91.245

10.  Risk of moderate to advanced kidney disease in patients with psoriasis: population based cohort study.

Authors:  Joy Wan; Shuwei Wang; Kevin Haynes; Michelle R Denburg; Daniel B Shin; Joel M Gelfand
Journal:  BMJ       Date:  2013-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.